Explore our ISO 13485 & CE-certified portfolio of absorbable polymers, advanced wound dressings, and surgical hemostatic supplies engineered for hospital networks and veterinary clinics.
An in-depth analysis of matrix pore-size architecture, hydrolytic degradation mechanisms, and clinical performance parameters for B2B procurement and hospital tender qualification.
In modern surgical interventions—spanning cardiovascular, orthopedic, neurological, and general visceral procedures—spontaneous intraoperative bleeding presents a critical challenge. Traditional mechanical control methods such as suturing or electrocautery are frequently inadequate when dealing with diffuse capillary oozing, fragile parenchymal tissue surfaces, or anatomically confined surgical sites. As a premier OEM/ODM Hemostatic Sponge Manufacturer & Supplier, our research and production infrastructure focuses on solving these clinical bottlenecks through bio-engineered polymer matrices, highly purified porous gelatin formulations, and Oxidized Regenerated Cellulose (ORC) materials.
Absorbable hemostatic sponges act as dual-action bioactive scaffolds. Physically, their micro-porous architecture (engineered with an optimal pore diameter distribution between 50 μm and 200 μm) creates an intense capillary suction effect, absorbing up to 45 times its dry weight in blood and cellular fluids. This rapid fluid uptake concentrates endogenous platelets, fibrinogen, and thrombin within the internal matrix voids. Biologically, the structural contact with native matrix proteins triggers thrombocyte activation, accelerating the natural coagulation cascade to achieve complete physiological hemostasis in under 120 seconds.
Manufactured from pharmaceutical-grade porcine gelatin. Cross-linked under vacuum thermal cycles to provide structural integrity that absorbs fully within 3 to 5 weeks without encapsulated fibrous tissue reaction.
Derived from high-purity Alpha-cellulose. Possesses intrinsic broad-spectrum antibacterial activity against gram-positive and gram-negative pathogens due to its low pH carboxylate chemistry.
Complimentary wound closure line using braided Polyglactin 910 and Polyglycolic Acid. Engineered for smooth tissue passage, high initial tensile strength, and zero monomer residue.
Rigorous quantitative comparison of physical properties, absorption kinetics, and regulatory classification parameters across major absorbable surgical materials.
| Hemostatic Material / Product | Primary Composition | Absorption Period | Hemostasis Speed | Inherent Antimicrobial | MDR / Regulatory Class |
|---|---|---|---|---|---|
| Absorbable Gelatin Sponge | Purified Porcine Gelatin Matrix | 21 – 35 Days | 1.5 – 3.0 Mins | No (Sterile Inert) | Class III (EU MDR / FDA) |
| Oxidized Regenerated Cellulose | Carboxymethylated Alpha-Cellulose | 7 – 14 Days | 1.0 – 2.5 Mins | Yes (Low pH Effect) | Class III (EU MDR) |
| Polyglactin 910 (PGLA) Suture | Copolymer (90/10 Glycolide-Lactide) | 56 – 70 Days | N/A (Mechanical Closure) | Option (Triclosan Coated) | Class III (CE Certified) |
| Polyglycolic Acid (PGA) Suture | Homopolymer 100% Polyglycolic Acid | 60 – 90 Days | N/A (Mechanical Closure) | No | Class III (ISO 13485) |
| Silicone Foam Dressing | Hydrophilic Polyurethane + Silicone | Non-Absorbable (External) | Fluid Management | Option (Silver Ions) | Class IIb (Wound Care) |
As an experienced medical device partner, we empower international procurement agencies, contract brands, and hospital supply chains to launch private-label hemostatic solutions with full regulatory backing. From customized density tuning to turnkey sterile packaging, our engineers provide complete lifecycle support.
Key shifts shaping strategic sourcing, regulatory hurdles, and next-generation biomaterial adoption in hospital tender channels.
Global hospital tenders are rapidly phasing out passive mechanical gauges in favor of composite hemostats combining micro-porous gelatin with recombinant human thrombin or antimicrobial silver compounds to drastically reduce ICU stay durations.
Reclassification of hemostatic sponges to Class III devices demands stringent post-market clinical follow-up (PMCF) and biocompatibility data under ISO 10993. Sourcing from accredited OEM plants with pre-validated dossiers is now essential for survival.
Healthcare conglomerates are moving away from single-source Western brands toward certified OEM hub manufacturers in Asia capable of offering equivalent clinical efficacy at 40-60% lower unit economics with stable buffer stocks.
Direct answers regarding sample dispatch, minimum order quantities (MOQ), regulatory technical support, and shelf-life stability.
We manufacture purified porcine gelatin sponges, Oxidized Regenerated Cellulose (ORC) textiles, microfibrillar collagen pads, and custom synthetic PGA/PGLA absorbable matrices. All materials can be customized for absorption speed and density.
For standard catalog sizes, our MOQ starts as low as 1,000 units. For fully customized private-label foil pouches, custom box artwork, and specialized needle swaging, our standard MOQ is typically 5,000 to 10,000 packs depending on specifications.
Products undergo double-pouch sterile barrier packaging inside ISO Class 8 cleanrooms followed by validated Ethylene Oxide (EO) or Gamma irradiation processing to a Sterility Assurance Level (SAL) of 10⁻⁶. Accelerated and real-time aging tests support a certified 5-year shelf life.
Yes. We supply comprehensive regulatory dossiers (CTD Module 3 format), ISO 13485 certificates, CE Certificates of Conformity, Free Sale Certificates (FSC), Biocompatibility Reports (ISO 10993 series), and Sterilisation Validation summaries to expedite your import approvals.
Standard inventory ships within 2 to 3 weeks. Initial private-label packaging production takes approximately 4 to 5 weeks after artwork approval. Repeat OEM production cycles run on an expedited 3-week timeline.
We supply complimentary sample kits (including suture boxes, hemostatic sponges, and foam dressings) for physical evaluation, needle pull-out strength testing, and laboratory verification by your quality control team.
Streamline your medical device supply chain with certified absorbable biomaterials, custom suture swaging, and complete regulatory dossiers. Contact our technical export team today for factory-direct quotes and sample kits.
